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Abstract In preventing postoperative adhesion formation
the optimal barrier material has still not been found. It is
therefore imperative to assess the biocompatibility of
potential barrier devices. Macrophages play a decisive role
in the regulation of wound healing, tissue regeneration and
foreign body reaction. Since the number of CD68-positive
macrophages represents an important parameter within
biomaterial testing, in the present study it was analysed
whether a correlation exists between the total number of
CD68-positive macrophages and the extent of ﬁbrosis or
inﬂammation in peritoneal adhesion prevention using bio-
materials. After standardized peritoneal wounding, Wistar
rats were treated with ﬁve adhesion barriers or remained
untreated as a control. After 14 days, animals were sacri-
ﬁced and the treated areas were evaluated histomorpholo-
gically and immunohistologically. A heterogeneous pattern
of macrophage count in relation to ﬁbrosis or inﬂammation
was found. While some groups described a moderate
macrophage inﬁltration without ﬁbrosis, others showed
similar numbers of macrophages, but accompanied by
moderate ﬁbrosis. Moreover, a minimal number of macro-
phages was associated with minimal ﬁbrosis. Mild inﬂam-
mation was seen both with minimal and moderate
macrophage inﬁltration. Altogether, no correlation could be
established between the tissue response and the count of
CD68-positive macrophages. With a view to macrophage
heterogeneity further studies are required to determine the
different macrophage subpopulations and clarify the role of
these in the tissue responses to barrier materials.
1 Introduction
Postoperative adhesion formation occurs in up to 90% of
patients undergoing abdominal or pelvic surgery [1] and
remains a clinical burden within all surgical specialties [2].
Peritoneal adhesions cause serious symptoms like infertility,
which often affects young women [3], as well as intestinal
obstruction [4, 5], chronic abdominal and pelvic pain [6–8].
Furthermore, the treatment of peritoneal adhesion formation
causes costs up to US $1.3 billion per year in the United
States alone [9, 10].
As a result of a complex cellular cascade, postoperative
adhesion formation is not yet completely understood. Various
humoral factors such as cytokines and signalling molecules
are crucially involved. The intact peritoneum, consisting of
highly functionalized mesothelial cells, creates smoothness of
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all surfaces inside the peritoneal cavity and ensures friction-
less gliding of intraperitoneal organs by producing surfactant
[11, 12] and phosphatidylcholine [13]. In addition, mesothe-
lial cells also have antithrombogenic properties and express
tissue plasminogen activator (tPA) as well as plasminogen
activator inhibitor (PAI) to provide the ﬁbrinogenic and
ﬁbrinolytic balance inside the peritoneal cavity [14]. Fur-
thermore, the mesothelium is actively involved in the reg-
ulation of the inﬂammatory response and the coagulation
system by expressing cell adhesion molecules [15–18]. Dur-
ing peritoneal damage the functionality of mesothelial cells is
disturbed [16]. As a result, tissue damage is followed by local
ischaemia, inﬂammation and an imbalance of the
procoagulatory-ﬁbrinolytic system with a predominance of
procoagulation [14]. Pathophysiologically, ﬁbrin is exudated
as one of the very ﬁrst steps during the wound healing process
after tissue damage. In adhesion formation the preference for
coagulation and the inhibition of the ﬁbrinolytic system lead
to a decreased ﬁbrin degradation compared to normal
conditions [19]. Subsequently, the formation of ﬁbrin bridges
to neighbouring tissue occurs and these become organized
into a connective tissue, which is the ﬁnal stage of
adhesion formation [20–23]. Clinically, the main strategy in
the prevention of postoperative adhesion formation is the use
of physical barriers, which separate wounded areas from their
environment and so prevent the formation of ﬁbrin
bridges and hence peritoneal adhesions [24]. Various barrier
materials are available in the form of solid or viscous
biomaterials and are currently in clinical use (Table 1) [25,
26].
Macrophages play a decisive role in inﬂammation and in
wound healing [27]. These cells are able to produce
proinﬂammatory cytokines and to phagocytose in order to
eliminate pathogens as well as foreign materials [28]. Fur-
thermore, macrophages secrete various growth factors and
signalling molecules and are thus involved in the regulation
of inﬂammation, wound healing and tissue repair [29].
Since these processes are part of adhesion formation,
macrophages are crucially involved in the regulation and
modulation of their formation and in the tissue reaction to
different barrier materials. To gain further insight into the
role of macrophages in the tissue response to barrier
materials used to prevent the formation of postoperative
adhesions, the present study evaluated the macrophage
response semi-quantitatively after the application of ﬁve
different adhesion barrier materials in an animal model.
These were Adept®, Intercoat®, Spraygel®, Sepraﬁlm®,
SupraSeal® and one control group. Since the count of
macrophages is an important parameter in biocompatibility
testing according to the ISO standard 10993-6 “Biological
evaluation of medical devices—Part 6: Tests for local
effects after implantation” [30], no attempt was made to
identify macrophage subpopulations, but rather to delineate
whether the total macrophage inﬁltration correlates with the
tissue response as seen by total inﬂammation and ﬁbrosis.
2 Materials and methods
2.1 The animal study
This study was approved by The Ethics Committee of the
Institutional Review Board, University of Tuebingen, Tue-
bingen, Germany (trial number F1-06).
The female Wistar rats (Charles River, Sulzfeld,
Germany) used in this investigation had a weight range
between 230–270 g and were housed under standardised
laboratory conditions (temperature 21± 2 °C, humidity
55% ± 10%, 12:12 h light-dark-cycle). All interventions
were performed by the same surgeon and by using powder-
free gloves under aseptic conditions. The animals were
anaesthetised with ketamine (100 mg/kg) and xylacine
(5 mg/kg).
2.2 Experimental adhesion induction
After a midline incision of 5 cm length and opening of the
peritoneal cavity, bilateral peritoneal damage of a dimension
of 20 × 5mm was induced via electrocautery (Vio 300D
bipolar generator set to 40W; ERBE Elektromedizin,
Tubingen, Germany), and subsequently ﬁve interrupted
sutures were placed (3–0 Vicryl; Ethicon, Somerville, NJ).
Afterwards, the lesions were treated with one of the fol-
lowing commercially available barrier materials: Adept®
(Baxter, Deerﬁeld, Illinois, USA) (n= 7), Intercoat® (Ethi-
con, New Brunswick, New Jersey, USA) (n= 7), Spraygel®
Table 1 The barrier materials used in this study
Barrier Manufacturer Components
Adept® ML Laboratories PLC, Hampshire, UK Icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
Spraygel® Conﬂuent Surgical Inc.,Waltham, MA, USA Polyethylene-glycol, water
Intercoat® Ethicon, Somerville, NJ, USA Carboxymethylcellulose, polyethylene oxide
Sepraﬁlm® Genzyme, Cambridge, MA, USA Sodium hyaluronic acid with carboxymethylcellulose
SupraSeal® PolyMedics Innovations GmbH, Poly-DL-lactic acid, trimethylencarbonate Denkendorf, Germany and ε-caprolactone
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(Conﬂuent Surgical Inc., Waltham, Massachusetts, USA)
(n= 7), Sepraﬁlm® (Genzyme, Cambridge, Massachusetts,
USA) (n= 7) or SupraSeal® (PolyMedics Innova-
tions GmbH, Denkendorf, Germany) (n= 7). The used bar-
riers in this study and their components are summarized in
Table 1. As control, one group remained untreated after
laparotomy and peritoneal damage. Each group contained
seven animals. The midline incision was then closed and the
animals were treated with subcutaneous buprenorphine (0.05
mg/kg) for analgesia. Fourteen days postoperatively, the
animals were sacriﬁced with CO2 and the treated tissue was
explanted and ﬁxed in buffered formalin (4%).
2.3 Tissue preparation and histological staining
The ﬁxed tissue was dehydrated via standardised, auto-
mated protocols and embedded in parafﬁn. From the par-
afﬁn blocks sections of 4 µm thickness were cut. For
histological evaluation, the specimens were stained with
haematoxylin-eosin (HE) to evaluate the overall histology
of the tissue and chloracetate esterase (ASD) to evaluate the
amount of granulocytes. Furthermore, the Elastica van
Gieson (EvG) stain was performed to score the extent of
ﬁbrosis. All histochemical staining reactions were per-
formed according to standardized operating procedures.
For the quantiﬁcation of macrophages immunohisto-
chemical staining of CD68 was performed using a mono-
clonal antibody (dilution 1:600, Santa Cruz Biotechnology,
Heidelberg Germany) with help of a standardized auto-
mated immunostaining-kit (Dako Cytomation Autostainer
Plus, Dako, Hamburg, Germany). The nuclei were coun-
terstained with haematoxylin (EN VisionTM Flex Haema-
toxyline, Dako Denmark A/S, Glostrup, Denmark).
2.4 Data acquisition and evaluation
The evaluation occurred semi-quantitatively. The inﬂam-
matory response was investigated in all specimens by
determining the population of polymorphonuclear granulo-
cytes in the ASD-staining and of lymphocytes/plasma cells
in the HE stain. Furthermore, the foreign body-type
multinucleated giant cells were counted in the HE stain. The
extent of ﬁbrosis was evaluated in the Elastica van Gieson
staining. Macrophages were counted with the help of CD68
immunostaining. All specimens were analysed for each
stain and for every variable by evaluating a total of 20 high
power ﬁelds (magnitude ×400) using an Olympus BX40
light microscope (Olympus GmbH, Hamburg, Germany). In
each specimen, ten of these high power ﬁelds were ran-
domly chosen and scored within the lesion. For this pur-
pose, high power ﬁelds were investigated which were near
the barrier material. In the control group and in the case no
material was histologically detected the high power ﬁelds
were chosen near the wound or peritoneal adhesion
respectively. The other ten high power ﬁelds assessed the
tissue at a distance from the treated area. The cells of
interest were counted and the amount of ﬁbrosis was scored
likewise adjacent to and at a distance from the lesion. In the
evaluation the values of cell count and ﬁbrosis in the non-
treated region were subtracted from the values within the
treated area. This generated a so called ‘barrier value’, by
which the pathophysiological conditions other than the
treatment were eliminated from the score. The generation of
the ‘barrier value´ enabled the evaluation and comparison of
the isolated effect of the barriers onto the tissue. Conse-
quently, in this model, the tissue response to the speciﬁc
barrier material can be considered objectively by minimiz-
ing the potential effects of the individual animal’s basal
reaction to the wound healing process itself.
2.5 Evaluation score
The evaluation score of the “ISO 10993-6: Biological eva-
luation of medical devices—Part 6: Tests for local effects
after implantation” was chosen to assess the histological
ﬁndings (Table 2) [30].
2.6 Statistical analysis
SPSS Statistics 17.0 was used for statistical analyses. All
groups were compared by pairs with the Mann-Whitney-U
test and the Kruskal-Wallis test at a signiﬁcance level of
Table 2 The evaluation score of the tissue response according to [30]
Tissue response Score
None Minimal Mild Moderate Severe
Polymorphonuclear granulocytes 0 Rare, 1–5/hpf* 5–10/hpf Heavy inﬁltrate Packed
Lymphocytes/plasma cells 0 Rare, 1–5/hpf 5–10/hpf Heavy inﬁltrate Packed
Foreign body-type multinucleated giant cells 0 Rare, 1–2/hpf 3–5/hpf Heavy inﬁltrate Sheets
CD68-positive macrophages 0 Rare, 1–5/hpf 5–10/hpf Heavy inﬁltrate Packed
Fibrosis 0 Narrow band Moderate band Broad band Extensive band
* hpf high power ﬁeld (400× magnitude)
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p< 0.05. Regarding the extent of ﬁbrosis, the chi-square test
and contingency tables were used. The statistical results
(median, ﬁrst quarter (Q1), third quarter (Q3), minimum,
maximum) are given in Tables 3–5 and are illustrated in
Figs. 1–3 via boxplots. In the following text, the median is
described for each variable in each group. Further, Pearson
product-moment correlation coefﬁcient was used for corre-
lation analysis.
3 Results
3.1 Overall tissue response
First, the tissue response to each barrier is described to
outline the impact of each material on the tissue (Figs. 1–3,
Tables 3–5).
The time-point 14 days was used for the histo-
morphological analysis, since at that time the material-
induced macrophage-ﬂux could be analysed. During normal
peritoneal wound healing the maximum of macrophage
inﬁltration is given by the days 2–4, and the serosal wound
healing is always completed within day 10–11 [22]. In this
scenario ﬁbroblast inﬁltration and collagen formation is also
completed after day 10–11. So we assumed the reaction that
was observed at day 14 was given due to the cellular
reaction on the used biomaterial.
The deﬁnition of a ﬁbrosis was given according to the
ISO-standard by an increase of collagen ﬁbres and ﬁbro-
blasts resulting in a dense cellular intermingled collagen
network, which properly could be illustrated within the
Elastica van Gieson staining [26]. The thickness of these
bands was deﬁned in “narrow band,” “moderate band,”
“broad band” and “extensive band” [29].
Table 3 Semi-quantitative results of the control- and the Adept® group
Barrier Tissue response Median Q1/Q3 Minimum Maximum
Control group Granulocytes Near the lesion 3.5 2.4/5.1 2.1 12.0
Afar from the lesion 1.4 0.6/2.4 0.4 3.3
Barrier value 1.8 1.3/4.1 1.1 8.7
Lymphocytes/plasma cells Near the lesion 0.2 0/1.1 0 1.6
Afar from the lesion 0 0/0.1 0 0.1
Barrier value 0.2 0/1 0 8.7
Macrophages Near the lesion 7.1 5.2/10.2 2.9 36.7
Afar from the lesion 1.9 0.6/2.4 0 2.7
Barrier value 5.2 3/10.2 2.3 34.3
Foreign body-type multinucleated Near the lesion 0 0/0 0 0.3
giant cells Afar from the lesion 0 0/0 0 0
Barrier value 0 0/0 0 0.3
Band of ﬁbrosis Near the lesion Moderate Moderate/broad Narrow Broad
Afar from the lesion Narrow Narrow/moderate Narrow Moderate
Barrier value Narrow None/moderate None Moderate
Adept® group Granulocytes Near the lesion 4 3.8/6.7 3.7 8.7
Afar from the lesion 1.7 1.3/2.4 0.6 3.7
Barrier value 2.5 1.8/3 1.6 8.1
Lymphocytes/plasma cells Near the lesion 0.4 0.1/0.7 0 3.3
Afar from the lesion 0.1 0/0.2 0 0.3
Barrier value 0.3 −0.1/0.7 −0.2 3.3
Macrophages Near the lesion 5.4 1.3/7.4 0.5 12.8
Afar from the lesion 1.4 0.8/4.5 0.5 5
Barrier value 3.2 0.8/4.6 −0.9 7.8
Foreign body-type multinucleated Near the lesion 0.6 0.3/1.4 0.2 2.4
giant cells Afar from the lesion 0.1 0/0.1 0 0.1
Barrier value 0.5 0.3/1.3 0.1 2.3
Band of ﬁbrosis Near the lesion Moderate Moderate/broad Moderate Extensive
Afar from the lesion Narrow Narrow/narrow Narrow Moderate
Barrier value Narrow Narrow/moderate Narrow Broad
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3.1.1 The control group
The animals of the control group (n= 7) (Table 3) showed a
ﬂat mesothelial cell layer and blood vessels with only
minimal inﬁltration with polymorphonuclear granulocytes
and no lymphocytes or plasma cells in the areas near the
lesion (Fig. 4a). There was a mild inﬁltration with macro-
phages (Fig. 4b), but no foreign body-type multinucleated
giant cells were detected. The band of ﬁbrosis adjacent to the
lesion was moderate. Areas at a distance from the lesion
revealed minimal granulocytic and no lymphocytic or
plasma cellular inﬁltration. The inﬁltration with macro-
phages was minimal and no foreign body-type multi-
nucleated giant cells were observed. The band of ﬁbrosis
was narrow in areas away from the wound. The barrier value
of polymorphonuclear granulocytes was shown to be a
minimal inﬁltration but without any lymphocytes or plasma
cells. There was a mild inﬁltration with macrophages. No
foreign body-type multinucleated giant cells were present.
The barrier value of the control group revealed a narrow
band of ﬁbrosis (Fig. 1a). The results of the tissue reaction of
the control group are given in detail in Table 3 and Fig. 1a.
3.1.2 Adept®
In the Adept® group (n= 7) ﬂat mesothelium-covered
connective tissue with blood vessels and subjacent muscle
was present with a minimal polymorphonuclear granulo-
cytic inﬁltration and no presence of lymphocytes or plasma
cells in the areas near the barrier (Fig. 4c). The inﬁltration
with macrophages was mild (Fig. 4d) and no foreign body-
type multinucleated giant cells were seen. Near the barrier, a
moderate ﬁbrous band was apparent. In areas far from the
barrier, a mild polymorphonuclear granulocytic but no
Table 4 Semi-quantitative results of the Intercoat-® and the Spraygel® group
Barrier Tissue response Median Q1/Q3 Minimum Maximum
Intercoat® group Granulocytes Near the lesion 1.4 1/2.6 0.5 3.2
Afar from the lesion 0.4 0.2/0.5 0.1 1.2
Barrier value 1.1 0.6/1.4 0.4 2.7
Lymphocytes/plasma cells Near the lesion 0.3 0.2/1 0.2 1.6
Afar from the lesion 0.1 0.1/0.7 0 2.7
Barrier value 0.1 −0.2/0.3 −1.7 0.9
Macrophages Near the lesion 44.9 28/57.5 21.7 80.8
Afar from the lesion 12.2 1.2/28.1 0.8 50.7
Barrier value 28.8 20.5/35.2 17.7 42.8
Foreign body-type multinucleated Near the lesion 0 0/0 0 0
giant cells Afar from the lesion 0 0/0 0 0
Barrier value 0 0/0 0 0
Band of ﬁbrosis Near the lesion Broad Narrow/extensive Narrow Extensive
Afar from the lesion Narrow Narrow/narrow Narrow Moderate
Barrier value Moderate None/moderate None Broad
Spraygel® group Granulocytes Near the lesion 9.1 4.6/29.4 4.4 32.2
Afar from the lesion 1.7 0.8/2.1 0.5 3.1
Barrier value 7 3.9/28.6 2.9 30.5
Lymphocytes/plasma cells Near the lesion 0.2 0/0.4 0 1.7
Afar from the lesion 0 0/0.1 0 0.1
Barrier value 0.1 0/0.4 0 1.6
Macrophages Near the lesion 24.2 7.4/29.8 6.8 41.6
Afar from the lesion 7.5 2.5/9.3 1.1 18.3
Barrier value 10.3 4.9/20.5 1.9 34.1
Foreign body-type multinucleated Near the lesion 0.1 0/0.2 0 0.3
giant cells Afar from the lesion 0 0/0 0 0
Barrier value 0.1 0/0.2 0 0.3
Band of ﬁbrosis Near the lesion Moderate Narrow/broad Narrow Extensive
Afar from the lesion Narrow Narrow/moderate Narrow Moderate
Barrier value None None/moderate None Broad
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lymphocytic or plasma cellular inﬁltration was seen. The
inﬁltration with macrophages was mild and no foreign
body-type multinucleated giant cells were present in remote
areas. The band of ﬁbrosis was narrow in the areas at a
distance from the barrier. The barrier value of the Adept®
group gave minimal amounts of polymorphonuclear gran-
ulocytes and no lymphocytes or plasma cells. The inﬁltra-
tion with macrophages was minimal and no foreign body-
type multinucleated giant cells were detectable. The band of
ﬁbrosis was narrow (Fig. 1b). Table 3 and Fig. 1b provides
a detailed description of the results of the Adept® group.
3.1.3 Intercoat®
In areas near the barrier, the animals treated with Intercoat®
(n= 7) presented ﬂat mesothelial cells on top of connective
tissue with blood vessels with a minimal inﬁltration of
polymorphonuclear granulocytes and no lymphocytes or
plasma cells (Fig. 4e). The inﬁltration with macrophages
was moderate to severe (Fig. 4f). No foreign body-type
multinucleated giant cells were present and the band of
ﬁbrosis was broad adjacent to the barrier. Distant areas
revealed no polymorphonuclear granulocytes and no lym-
phocytes/plasma cells. Inﬁltration with macrophages was
moderate and notably less compared to the inﬁltration
adjacent to the barrier. No foreign body-type multinucleated
giant cells were seen and the band of ﬁbrosis was narrow
near the barrier. The barrier value of the Intercoat® group
exhibited mild amounts of polymorphonuclear granulocytes
but no lymphocytes or plasma cells. The inﬁltration with
macrophages was moderate to severe. No foreign body-type
multinucleated giant cells were present. The band of ﬁbrosis
Table 5 Semi-quantitative results of the Sepraﬁlm-® and the SupraSeal® group
Barrier Tissue response Median Q1/Q3 Minimum Maximum
Sepraﬁlm® group Granulocytes Near the lesion 1.6 1/3.9 0.9 5.1
Afar from the lesion 0.5 0.4/0.8 0.3 2.5
Barrier value 1.1 0.5/2.2 0.5 4.3
Lymphocytes/plasma cells Near the lesion 0.2 0.1/0.2 0 1.3
Afar from the lesion 0 0/0.3 0 0.4
Barrier value 0.2 0/0.2 −0.1 0.9
Macrophages Near the lesion 23.8 13.1/24.8 1 48.1
Afar from the lesion 7 2.6/19.6 1.8 33.6
Barrier value 10.5 5.2/14.5 −0.8 18.9
Foreign body-type multinucleated Near the lesion 0 0/0 0 0.1
giant cells Afar from the lesion 0 0/0 0 0
Barrier value 0 0/0 0 0.1
Band of ﬁbrosis Near the lesion Moderate Narrow/broad Narrow Broad
Afar from the lesion Narrow Narrow/narrow Narrow Broad
Barrier value Narrow None/narrow None Moderate
SupraSeal® group Granulocytes Near the lesion 23.2 3.8/30.1 0.6 62.9
Afar from the lesion 0.7 0.6/1.7 0.4 1.9
Barrier value 21.5 2.7/29.5 0 61
Lymphocytes/plasma cells Near the lesion 0 0/0.2 0 0.4
Afar from the lesion 0 0/0.1 0 0.9
Barrier value 0 0/0.1 −0.5 0.1
Macrophages Near the lesion 36.6 22.5/47.2 11.9 54.3
Afar from the lesion 4.3 2/14.2 1.3 16.9
Barrier value 32.4 20.5/37.4 7.6 40.1
Foreign body-type multinucleated Near the lesion 0.5 0.3/0.8 0 2.1
giant cells Afar from the lesion 0 0/0.1 0 0.2
Barrier value 0.5 0.3/0.7 −0.1 2
Band of Fibrosis Near the lesion Narrow Narrow/narrow Narrow Broad
Afar from the lesion Narrow Narrow/narrow Narrow Moderate
Barrier value None None/none None Narrow
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was of a moderate degree (Fig. 2a). Detailed information
about the tissue response to Intercoat® is given in (Table 4
and Fig. 2a).
3.1.4 Spraygel®
In the Spraygel® group (n= 7) submesothelial abscess
formation was detected with severe inﬁltration of poly-
morphonuclear granulocytes and cell detritus (Fig. 5a). In
the absence of abscesses, the tissue often showed only few
inﬂammatory cells. In the entire assessment a mild inﬁl-
tration with polymorphonuclear granulocytes and no lym-
phocytes/plasma cells were observed in the areas near the
barrier (Table 4). The inﬁltration with macrophages was
moderate (Fig. 5b). No foreign body-type multinucleated
giant cells were present near the barrier and the band of
ﬁbrosis was moderate. Areas at a distance from the barrier
showed minimal amounts of polymorphonuclear granulo-
cytes and no lymphocytes or plasma cells. The inﬁltration
with macrophages was mild and no foreign body-type
Fig. 2 The tissue response to (a) the Intercoat® and (b) the Spraygel®
group regarding polymorphonuclear granulocytes, lymphocytes/
plasma cells, foreign body giant cells, ﬁbrosis and macrophages. Here,
moderate macrophage inﬁltration was accompanied with a minimal
inﬂammatory response in the animals treated with Intercoat® and mild
inﬂammation in the Spraygel® group. Regarding ﬁbrosis, both a
moderate extent (Intercoat®) and no ﬁbrosis (Spraygel®) were seen
with moderate macrophage inﬁltration
Fig. 1 Comparison of the tissue response of the (a) control group and
(b) animals treated with Adept® regarding the count of cells and
degree of ﬁbrosis using boxplots. Minimal and mild macrophage
inﬁltrations were both accompanied with a minimal inﬂammatory
response in these groups. Also, in these animals minimal ﬁbrosis was
accompanied with mild (control group) and minimal (Adept®) inﬁl-
tration of macrophages
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multinucleated giant cells were present in areas distant to
the barrier. Furthermore, the band of ﬁbrosis was narrow.
The barrier value revealed a mild polymorphonuclear
granulocytic inﬁltration and no lymphocytes or plasma
cells. The inﬁltration with macrophages was moderate. No
foreign body-type multinucleated giant cells and no ﬁbrosis
were present. Table 4 and Fig. 2b provides the results of the
tissue response to Spraygel® in detail.
3.1.5 Sepraﬁlm®
In the animals treated with Sepraﬁlm® (n= 7) a mild inﬁl-
tration with polymorphonuclear granulocytes and no lym-
phocytes or plasma cells were seen near the barrier
(Fig. 5c). The inﬁltration with macrophages was moderate
(Fig. 5d). No foreign body-type multinucleated giant cells
were present and the band of ﬁbrosis was moderate near
the barrier. Areas at a distance from the barrier revealed
neither polymorphonuclear granulocytes nor lymphocytes
or plasma cells. The inﬁltration with macrophages was mild
and no foreign body-type multinucleated giant cells were
present. The barrier-remote areas exhibited a narrow band
of ﬁbrosis. The barrier value of the Sepraﬁlm® group pre-
sented a minimal polymorphonuclear granulocytic inﬁltra-
tion without any lymphocytes or plasma cells. The
inﬁltration with macrophages was moderate and no
foreign body-type multinucleated giant cells were detected.
The band of ﬁbrosis was narrow (Fig. 3a). The detailed
results of the Sepraﬁlm® group are shown in Table 5 and
Fig. 3a.
3.1.6 SupraSeal®
In the SupraSeal® group (n= 7) a dense layer of ﬂat
mesothelial cells covered connective tissue containing
blood vessels (Fig. 5e). The inﬁltration with polymorpho-
nuclear granulocytes was moderate and lymphocytes or
plasma cells were not present in areas near the barrier
(Table 5). The inﬁltration with macrophages was moderate
(Fig. 5f) and no foreign body-type multinucleated giant
cells were present near the barrier. The band of ﬁbrosis was
narrow. In the areas away from the barrier, neither poly-
morphonuclear granulocytes nor lymphocytes or plasma
cells were present. A minimal inﬁltration with macrophages
was observed and no foreign body-type multinucleated
giant cells were seen. The band of ﬁbrosis was narrow in the
remote areas. The barrier value of the SupraSeal® group
revealed a moderate polymorphonuclear granulocytic inﬁl-
tration but without lymphocytes and plasma cells. The
barrier value of macrophages presented a moderate to
severe inﬁltration. No foreign body-type multinucleated
giant cells no ﬁbrosis was seen (Fig. 3b). Detailed infor-
mation about the tissue response to SupraSeal® is provided
in Table 5 and Fig. 3b.
3.2 Comparison of the different parameters of the tissue
response
In the following, the tissue response to the barriers is
directly compared with respect to the barrier value regard-
ing inﬂammation, foreign body reaction, ﬁbrosis and the
inﬁltration of macrophages (Table 6).
Fig. 3 Boxplots showing the tissue response to (a) Sepraﬁlm® and (b)
SupraSeal®. In these groups moderate macrophage inﬁltration was
seen with both a minimal (Sepraﬁlm®) and a moderate inﬂammatory
response (SupraSeal®). No ﬁbrosis was seen with moderate macro-
phage inﬁltration in the animals treated with SupraSeal® whereas in
the Sepraﬁlm® group minimal ﬁbrosis was accompanied with a
moderate inﬁltration of macrophages. Taken the results of Figs. 1–3
together, the count of macrophages did not go along with any type of
tissue response
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3.2.1 Comparison of the inﬂammatory response
The granulocytic inﬂammation was lowest in the animals
treated with Intercoat® and Sepraﬁlm®, both presenting a
median of 1.1 cells per high power ﬁeld. The control group
(median: 1.8 cells per high power ﬁeld) and the Adept® group
(median: 2.5 cells per high power ﬁeld) followed. According
to the quantity of cells, these four groups presented a minimal
Fig. 4 (a) The control group shows a ﬂat mesothelial cell layer
(arrows) and blood vessels (v) (HE ×200) as well as (b) some mac-
rophages (arrows) (CD68-staining ×200). (c) In the Adept® group, ﬂat
mesothelium (arrows)-covered connective tissue (*) with blood ves-
sels (v) and subjacent muscle (m) are seen (HE ×200). (d) Some
macrophages (arrows) were observed within the submesothelium
(CD68 staining ×400). (e) Intercoat® revealed ﬂat mesothelial cells
(arrows) on top of connective tissue with blood vessels (v) (HE ×400)
and (f) a considerable inﬁltration with (arrows) macrophages
(CD68 staining ×200)
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granulocytic inﬂammation. Spraygel® (median: 7 cells per
high power ﬁeld) revealed a mild granulocytic inﬂammation.
With a median of 21.5 cells per high power ﬁeld, SupraSeal®
was associated with the strongest granulocytic reaction.
Lymphocytes or plasma cells were only seen spor-
adically in small numbers. Regarding the scoring system
used in this study, there was no inﬁltration of lymphocytes
or plasma cells in any of the analysed groups in this study.
Fig. 5 (a) In the Spraygel® group submesothelial abscesses (*) were
present (HE ×20) as well as (b) a moderate inﬁltration with macro-
phages (CD68 staining ×200). (c) Sepraﬁlm® revealed minimal
amounts of granulocytes (arrows) and lymphocytes (*) (HE ×200) as
well as (d) moderate inﬁltration with macrophages (CD68 staining,
×200). (e) In the SupraSeal® group, a dense layer of ﬂat mesothelial
cells (arrows) covered connective tissue containing blood vessels (v)
(HE ×200). (f) There was a high presence of macrophages (arrows)
adjacent to the barrier (CD68 staining, ×100)
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SupraSeal® revealed none of these cells per high power
ﬁeld. Intercoat® and Spraygel® both presented a median of
0.1 cells per high power ﬁeld and the control group as well
as the Sepraﬁlm® group were both associated with a median
of 0.2 cells per high power ﬁeld. Adept® followed with 0.3
cells per high power ﬁeld.
Altogether, the inﬂammatory reaction was characterized
by granulocytic inﬁltration with a negligible lymphocytic or
plasma cellular reaction in all groups. Intercoat®, Sepra-
ﬁlm®, Adept® and the control group revealed a minimal
inﬂammatory response. The animals treated with Spraygel®
revealed mild inﬂammation, whilst the SupraSeal® group
presented a moderate inﬂammatory response.
3.2.2 Comparison of the foreign body reaction
No or regarding the score only minimal numbers of foreign
body giant cells were present in any group. The barrier
value of Intercoat®, Sepraﬁlm® and the control group
revealed no foreign body-type multinucleated giant cells per
high power ﬁeld at the median. Spraygel® followed, pre-
senting 0.1 cells per high power ﬁeld. Adept® and Supra-
Seal® both revealed a median of 0.5 cells per high power
ﬁeld in this study.
3.2.3 Comparison of the induced ﬁbrosis
Sepraﬁlm®, Adept® and the control group revealed a nar-
row band of ﬁbrosis. The Intercoat® group presented a
moderate band of ﬁbrosis in this study. In animals treated
with SupraSeal® and Spraygel® no ﬁbrosis was present.
3.2.4 Comparison of the amount of macrophages
The presence of macrophages was lowest in the Adept®
group (median: 3.2 cells per high power ﬁeld), which
revealed a minimal response. The control group (median:
5.2 cells per high power ﬁeld) followed and presented a
mild reaction. The animals treated with Spraygel® (median:
10.3 cells per high power ﬁeld) and Sepraﬁlm® (median:
10.5 cells per high power ﬁeld) were associated with a
moderate response, whilst the Intercoat-® (median: 28.8
cells per high power ﬁeld) and SupraSeal® group (median:
32.4 cells per high power ﬁeld) revealed a moderate to
severe reaction.
3.3 Correlation between the tissue response and the
amount of macrophages
The correlation analysis performed via the Pearson product-
moment correlation coefﬁcient revealed signiﬁcant corre-
lations between the foreign body reaction and the amount of
macrophages in the Adept® group (r> 0.6, p< 0.05),
whereas a negative correlation between macrophage inﬁl-
tration and the amount of ﬁbrosis was found in the Supra-
Seal® group (r< −0.6, p< 0.05). A correlation was present
between the quantity of macrophages and the presence of
granulocytes in the Intercoat® group (r> 0.6, p< 0.1),
whereas this trend was not seen in the evaluation of all
samples, where no correlation was found (−0.6< r< 0.6, p
< 0.1). The control group as well as the Adept®, Spraygel®
and Sepraﬁlm® groups all showed no correlation between
macrophage and granulocytic inﬁltration (−0.6< r< 0.6).
Regarding lymphocytes and plasma cells, a positive trend
was seen in the relationship between the amount of these
cells and the presence of macrophages in the SupraSeal®
group (r> 0.6, p< 0.1). Although not statistically sig-
niﬁcant, this result matched the ﬁndings in the Spraygel®
group (r> 0.6, p> 0.1), whereas other groups revealed no
correlation between lymphocytic and macrophage inﬁltra-
tion (−0.6< r< 0.6, p> 0.1). Concerning the foreign body
reaction the correlation analysis performed via the Pearson
product-moment correlation coefﬁcient showed a signiﬁcant
positive correlation between the number of macrophages
and the presence of foreign body giant cells in the Adept®
group (r> 0.6, p< 0.05). Interestingly, in the Sepraﬁlm®
group a negative correlation trend was detected (r< −0.6,
p< 0.1), whereas in the animals of the control group and
Table 6 The tissue response to the barrier types according to [30]
Barrier Inﬂammation Foreign body
reaction






Control Minimal None None Narrow band Mild
Adept® Minimal None None Narrow band Minimal
Intercoat® Minimal None None Moderate band Moderate–severe
Spraygel® Mild None None No ﬁbrosis Moderate
Sepraﬁlm® Minimal None None Narrow band Moderate
SupraSeal® Moderate None None No ﬁbrosis Moderate–severe
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those treated with Spraygel® and SupraSeal® no correlation
was seen (−0.6< r< 0.6, p> 0.1). A signiﬁcant negative
correlation between the inﬁltration of macrophages and the
amount of ﬁbrosis was seen in the SupraSeal® group
(r< −0.6, p< 0.05). In the other groups no correlation was
detected (−0.6< r< 0.6, p> 0.1). The results of the corre-
lation analysis performed via the Pearson product-moment
correlation coefﬁcient are presented in Table 7.
Altogether, signiﬁcant correlations were seen between the
foreign body reaction and the number of macrophages and a
negative correlation was present between macrophage inﬁl-
tration and the amount of ﬁbrosis. Statistical trends were
found between the amount of macrophages and granulo-
cytes, with a positive correlation in the Intercoat® group
(r> 0.6, p< 0.1) but no correlation for total samples (−0.6
< r< 0.6, p< 0.1). Moreover, a trend was seen regarding the
presence of macrophages and lymphocytic inﬁltration in the
SupraSeal® group (r> 0.6, p< 0.1), as well as a negative
correlation between macrophages and the number of foreign
body giant cells in the Sepraﬁlm® group (r< −0.6, p< 0.1).
Not all results reached statistical signiﬁcant, but overall it
could be shown that there is no clear correlation between the
quantity of macrophages and the tissue biocompatibility of
barrier materials regarding inﬂammation, foreign body
reaction or ﬁbrosis.
4 Discussion
Postoperative adhesion formation still represents a serious
clinical problem [25] and the pathomechanisms of this
condition are not yet completely understood. Furthermore,
adhesion formation seems to be the consequence of the
malfunction or imbalance of various mechanisms and fac-
tors occurring during or combined with peritoneal wound-
ing [14, 16]. Macrophages play a crucial role in the
modulation and regulation of inﬂammation and the immune
response, tissue repair, the induction and formation of
ﬁbrosis as well as the elimination of pathogens [27]. From
this point of view, these cells might also play a distinctive
role in postoperative adhesion formation. In the present
study, the tissue response to ﬁve commercially available
adhesion barriers and a sham-operated control group was
semi-quantitatively assessed with respect to inﬂammation,
foreign body reaction, extent of ﬁbrosis and the immigration
of macrophages to evaluate a possible correlation between
the tissue response and macrophage inﬁltration. As an
important result, no correlation between the number of
macrophages and any of the relevant parameters for tissue
reaction could be detected, even if the total amount of
macrophages differed within the various groups. In this
context it was an interesting ﬁnding that in the untreated
Table 7 Results of the correlation analysis performed via Pearson product-moment correlation coefﬁcient: Signiﬁcant correlations were seen
regarding the foreign body reaction and the amount of macrophages in the Adept® group (r> 0.6, p< 0.05)





Control group Pearson-Corr. −0.179 −0.390 0.040 0.165
n= 7 P 0.702 0.387 0.932 0.724
Adept® Pearson-Corr. 0.123 0.228 0.839 0.300
n= 7 P 0.793 0.624 0.018 0.514
Intercoat® Pearson-Corr. 0.727 0.209 0.246
n= 7 P 0.064 0.653 0.595
Spraygel® Pearson-Corr. −0.402 0.669 −0.311 −0.023
n= 7 P 0.371 0.101 0.497 0.961
Sepraﬁlm® Pearson-Corr. −0.403 −0.217 −0.711 0.367
n= 7 P 0.370 0.640 0.073 0.418
SupraSeal® Pearson-Corr. 0.491 0.712 0.324 −0.833
n= 7 P 0.263 0.073 0.478 0.020
All samples Pearson-Corr. 0.264 −0.167 0.017 −0.101
n= 42 P 0.091 0.290 0.917 0.526
Also, a signiﬁcant negative correlation between macrophage inﬁltration and the amount of ﬁbrosis was found in the SupraSeal® group (r< −0.6, p
< 0.05). Statistical trends were seen between the amount of macrophages and the inﬁltration of granulocytes (positive correlation in the Intercoat®
group, r> 0.6, p< 0.1 and no correlation regarding all samples, −0.6< r< 0.6, p< 0.1) as well as between the presence of macrophages and the
lymphocytic inﬁltration in the SupraSeal® group (r > 0.6, p< 0.1). Further, a trend to negative correlation between macrophages and the amount of
foreign body giant cells was seen in the Sepraﬁlm® group (r< −0.6, p< 0.1). Although not all results are signiﬁcant, mainly due to a low number
of animals per group, the results are interesting since they show that there is no clear correlation between the amount of macrophages and the
biocompatibility of barrier materials regarding inﬂammation, foreign body reaction or ﬁbrosis
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control group without any biomaterial implant a mild
macrophage inﬁltration was seen, whereas in the animal
group treated with Adept® merely a minimal inﬁltration of
macrophages was evident. In fact, there was a moderate
inﬁltration in the Spraygel® group and a moderate to
severe inﬁltration in the animals treated with SupraSeal®.
However, both latter groups showed no ﬁbrosis. In con-
trast, the Intercoat® group revealed a moderate to severe
macrophage inﬁltration with a moderate band of ﬁbrosis.
However, in the control and the Adept® group low counts
of macrophages were seen combined with minor ﬁbrosis.
So, moderate macrophage inﬁltration was seen with both
no and moderate extent of ﬁbrosis. Also, low inﬁltration of
macrophages was detected with minimal ﬁbrosis (Table 6)
[26]. These results are of special interest in view of the
existing literature, since macrophages are thought to be the
master regulators of ﬁbrosis, which is controlled by sev-
eral cytokines and signaling molecules, especially by
TGF-β1 [31]. It still has to be clariﬁed whether this reg-
ulation is based on the quantity of cells in the tissue or if it
is mainly regulated at a molecular level given by the type
and level of secreted cytokines, growth factors or signal-
ing molecules. It is evident that a count of macrophages
does not provide information about cell function. So in the
present study, moderate macrophage inﬁltration was seen
with both minimal and moderate inﬂammation (Table 6).
Hence, inﬂammation was moderate in the SupraSeal®
group with a moderate to severe macrophage inﬁltration.
By contrast, Intercoat® and Sepraﬁlm® revealed a minimal
inﬂammatory response with moderate and moderate to
severe inﬁltration with macrophages, respectively. Both
the Adept® and the untreated control group showed
minor values for overall inﬂammation and macrophage
inﬁltration.
Macrophages were classically deﬁned as phagocytic
cells, but in recent experimental studies it has become
apparent that they play a key role in the regulation of wound
healing, inﬂammation and ﬁbrosis [28, 32, 33]. According
to their activity as important regulators, the view of these
cells has changed completely, so that macrophages are no
longer described as a homogenous population of cells but
are divided into various subgroups according to their
functions [32–34]. The ‘classically activated macrophages’,
so called M1 macrophages, play an important role in host
defence. These cells eliminate pathogens via phagocytosis
and the production of O2 and N2 radicals [35]. Furthermore,
they participate in the degradation of the extracellular
matrix during inﬂammation [33] by secreting various
enzymes, including collagenases, elastase and hyalur-
onidase [36]. The ‘alternatively activated macrophages,’ or
M2 macrophages, are divided into at least three sub-
populations. Each group of these has various functions,
which are just beginning to be understood. In fact, some of
these cells, the M2a subtype, appear to play a crucial role in
wound healing and tissue remodelling by producing pro-
teins of the extracellular matrix [37, 38]. Another sub-
population, the M2b macrophage, is believed to play a
central role in the regulation and modulation of inﬂamma-
tory immune responses and thereby limits tissue damage.
The function of this macrophage type seems to be of a
purely regulatory quality since these cells synthesize and
secrete cytokines, growth factors and signalling molecules.
In contrast to the other subpopulations of M2 macrophages,
this type of macrophage does not produce extracellular
matrix proteins by itself and hence does not actively parti-
cipate in wound repair [39]. The third described phenotype
of M2, the M2c macrophage, is crucially involved in
immune suppression as well as in the modiﬁcation, reor-
ganization and degradation of the extracellular matrix.
These cells could be of special interest with respect to
postoperative adhesion formation since they are actively
involved in the induction of ﬁbrosis [37]. It is thought that,
on the one hand, M2 macrophages produce cytokines and
chemokines, which induce chemotaxis, proliferation and
activation of ﬁbroblasts into the lesion [40–43]. On the
other hand, these cells are capable of producing components
of the extracellular matrix, such as ﬁbronectin [27].
Therefore, the functions and mechanisms of the various
macrophage subpopulations might play an essential role in
the formation of postoperative adhesions [26].
5 Conclusion
In this study, no correlation was seen between the total
inﬁltration of macrophages and the tissue response in terms
of inﬂammation, foreign body reaction and ﬁbrosis. The
positive reaction for CD68 detects all types of macrophages
without differentiating the various macrophage phenotypes.
Based on these ﬁndings, it appears that the count of CD68-
positive macrophages is no longer expedient for the eva-
luation of the tissue response or biocompatibility of material
implants. As a consequence, since macrophages play deci-
sive roles in the regulation of the immune response, wound
repair and the host responses to biomaterial implants [33],
this cell type and its role in tissue response to biomaterials
should be further investigated also including its subtypes.
For this purpose, markers have to be deﬁned to precisely
identify the various subgroups in the important animal
model species as well as in humans. Moreover, with respect
to peritoneal adhesions, in further studies the macrophage
subpopulations should be assessed in postoperative adhe-
sion formation with and without the treatment with barrier
materials. These results should then be compared with the
tissue response regarding inﬂammation, foreign body reac-
tion and ﬁbrosis to explore a possible correlation and
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thereby possibly open up new strategies for the therapy or
prevention of postoperative adhesion formation.
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